Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

NCT05429632 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

366

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Acute Myeloid Leukemia

Interventions

DRUG: mocravimod

Sponsor

Priothera SAS